We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
AptarGroup Bets on Transformation Plan, Innovative Products
Read MoreHide Full Article
On May 23, we issued an updated research report on AptarGroup, Inc. (ATR - Free Report) . The company is poised to gain from its business-transformation plan, innovative product rollouts and acquisitions.
Let’s illustrate these factors in detail.
Business-Transformation Plan: A Key Growth Driver
In late 2017, AptarGroup began a business-transformation plan to drive the top line, boost operational excellence, enhance approach to innovation and improve organizational effectiveness. The company is on track with its business transformation which primarily focuses on the Beauty + Home segment. The company expects the business-transformation plan to yield incremental EBITDA of approximately $80 million by 2020-end.
Innovation Provides a Competitive Edge
AptarGroup is poised to gain from recent innovative product launches. In the Pharma segment, the Bidose Nasal Spray Device was recently approved by the U.S. FDA for breakthrough therapy in the field of depression. This vital system is a prime less, intuitive and easy to use device with 360-degree functionality and precise spray characteristic delivering two shots of medicine within the single device. This is the first FDA approval and U.S. launch of a prescription drug using AptarGroup’s patented Bidose Nasal Spray delivery system.
In the Beauty + Home segment, the company has Skin Care Dispensing Pen in China. It features a magnetic applicator which delivers active ingredients to each spot with three times the absorption rate than application with finger. In the Food + Beverage segment, the company has launched flip-lid closure with SimpliSqueeze Valve technology and a built-in tamper evident pull ring fitment for sauces and condiments.
Acquisitions to Grow Business
AptarGroup remains committed to business expansion through acquisitions to broaden the scope of technologies, geographic presence and product offerings. In sync with this, the company acquired CSP Technologies, a leader in active packaging technology based on proprietary material science expertise.
In May 2018, AptarGroup acquired 100% of the common stock of Reboul, a French manufacturer specializing in stamping, decorating and assembling metal and plastic packaging for the cosmetics and luxury markets. Moreover, the company has acquired several companies, including Stelmi, Mega Airless, and made a minority investment in Kali Care, Inc., over the past few years. Last year, it also expanded partnership with Propeller Health and made a strategic equity investment in the company. These acquisitions will drive growth.
Price Performance
AptarGroup’s shares have gained 20.1% over the past year, against the industry’s decline of 4.6%.
Investors interested in the Industrial Products sector can also consider other top-ranked players like DMC Global Inc. (BOOM - Free Report) , Lawson Products, Inc. and Roper Technologies, Inc. (ROP - Free Report) , each sporting a Zacks Rank #1.
DMC Global has an estimated earnings growth rate of 79.7% for the ongoing year. The company’s shares have soared 50% in the past year.
Lawson Products has a stellar expected earnings growth rate of 24.5% for the current year. The stock has appreciated 56% in a year’s time.
Roper Technologies has a projected earnings growth rate of 7.9% for 2019. The company’s shares have gained 25% over the past year.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
Image: Bigstock
AptarGroup Bets on Transformation Plan, Innovative Products
On May 23, we issued an updated research report on AptarGroup, Inc. (ATR - Free Report) . The company is poised to gain from its business-transformation plan, innovative product rollouts and acquisitions.
Let’s illustrate these factors in detail.
Business-Transformation Plan: A Key Growth Driver
In late 2017, AptarGroup began a business-transformation plan to drive the top line, boost operational excellence, enhance approach to innovation and improve organizational effectiveness. The company is on track with its business transformation which primarily focuses on the Beauty + Home segment. The company expects the business-transformation plan to yield incremental EBITDA of approximately $80 million by 2020-end.
Innovation Provides a Competitive Edge
AptarGroup is poised to gain from recent innovative product launches. In the Pharma segment, the Bidose Nasal Spray Device was recently approved by the U.S. FDA for breakthrough therapy in the field of depression. This vital system is a prime less, intuitive and easy to use device with 360-degree functionality and precise spray characteristic delivering two shots of medicine within the single device. This is the first FDA approval and U.S. launch of a prescription drug using AptarGroup’s patented Bidose Nasal Spray delivery system.
In the Beauty + Home segment, the company has Skin Care Dispensing Pen in China. It features a magnetic applicator which delivers active ingredients to each spot with three times the absorption rate than application with finger. In the Food + Beverage segment, the company has launched flip-lid closure with SimpliSqueeze Valve technology and a built-in tamper evident pull ring fitment for sauces and condiments.
Acquisitions to Grow Business
AptarGroup remains committed to business expansion through acquisitions to broaden the scope of technologies, geographic presence and product offerings. In sync with this, the company acquired CSP Technologies, a leader in active packaging technology based on proprietary material science expertise.
In May 2018, AptarGroup acquired 100% of the common stock of Reboul, a French manufacturer specializing in stamping, decorating and assembling metal and plastic packaging for the cosmetics and luxury markets. Moreover, the company has acquired several companies, including Stelmi, Mega Airless, and made a minority investment in Kali Care, Inc., over the past few years. Last year, it also expanded partnership with Propeller Health and made a strategic equity investment in the company. These acquisitions will drive growth.
Price Performance
AptarGroup’s shares have gained 20.1% over the past year, against the industry’s decline of 4.6%.
Zacks Rank & Other Stocks to Consider
AptarGroup currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Investors interested in the Industrial Products sector can also consider other top-ranked players like DMC Global Inc. (BOOM - Free Report) , Lawson Products, Inc. and Roper Technologies, Inc. (ROP - Free Report) , each sporting a Zacks Rank #1.
DMC Global has an estimated earnings growth rate of 79.7% for the ongoing year. The company’s shares have soared 50% in the past year.
Lawson Products has a stellar expected earnings growth rate of 24.5% for the current year. The stock has appreciated 56% in a year’s time.
Roper Technologies has a projected earnings growth rate of 7.9% for 2019. The company’s shares have gained 25% over the past year.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>